Siemens
siemens
siemens

Axonics® Launches Next Generation Neurostimulator to Treat Urinary, Bowel Dysfunction

Axonics Modulation Technologies launched its next-generation rechargeable Implantable Neurostimulator (INS) for its r-SNM® system.

The r-SNM system is implantable Sacral Neuromodulation (SNM) device for treating urinary and bowel dysfunction. The device decreases how frequently a patient needs to charge their implanted device to one month for about one hour.

The new feature will also give patients the option to customise charging, like choosing to charge for only 15 minutes once a week.

The device can be charged wirelessly through the skin once a month for about 1 hour. Those who have lower stimulation intensity levels can charge for 1 hour every 2 months.

The tiny neurostimulator is fixed through a minimally invasive outpatient procedure. Besides, the enhanced INS is also designed so that there’s virtually no battery degradation over the 15+ year life span of the implant due to the reduced charging burden.

Axonics r-SNM system is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or aren’t candidates for more conservative treatments.